Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

Influence of Primary Components on Parenteral Delivery Systems, Biologic Therapies and Patient Outcome

The administration of parenteral biologics relies on interconnected attributes associated with compatibility of delivery components to the safety and efficacy of the final product. Diane Paskiet and Simon Côté of WestPharma address the importance of characterising individual components in contact with a biologic, to understand the risks to the delivery system as a whole and the effect on patient outcome. And selecting an appropriate delivery system for these therapies is critically important.
https://international-pharma.com/wp-content/uploads/2014/07/Influence.pdf

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025